SYT1 (Synaptotagmin-1) is a neuronal calcium sensor protein that functions as the primary trigger for fast, synchronous neurotransmitter release at synapses. As a member of the synaptotagmin family, SYT1 contains two C2 domains that bind calcium with high affinity, enabling rapid coupling between action potential arrival and synaptic vesicle fusion.
Dysfunction of SYT1 has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), where synaptic vesicle recycling deficits contribute to neurodegeneration.
Gene Overview
Protein Structure
SYT1 is a 421-amino acid transmembrane protein with the following domain architecture:
N-terminal transmembrane region: Anchors the protein to synaptic vesicle membranes
C2B domain (residues 271-421): Calcium binding and oligomerization
The two C2 domains form a calcium-binding module that undergoes conformational changes upon calcium influx, enabling interaction with the SNARE complex [@suddhof2021].
Molecular Function
Calcium-Dependent Neurotransmitter Release
Synaptotagmin-1 is the primary calcium sensor for fast synchronous neurotransmitter release at central synapses. The mechanism involves several key steps:
Action potential arrival at the presynaptic terminal triggers opening of voltage-gated calcium channels
Calcium influx through these channels produces a rapid, localized rise in intracellular calcium concentration
SYT1 binds calcium (Kd ~10 μM) through its C2 domains, undergoing a conformational change
SNARE complex interaction: Calcium-bound SYT1 binds to the SNARE proteins (syntaxin-1, SNAP-25, VAMP2), accelerating vesicle fusion
Vesicle fusion and neurotransmitter release occur within 200 μs of calcium entry [@brocke2020]
Key Molecular Interactions
Disease Associations
Alzheimer's Disease
In Alzheimer's disease, SYT1 expression and function are significantly altered:
Synaptic vesicle cycling impairment: SYT1 levels are reduced in AD hippocampus, correlating with cognitive decline [@wang2021]
Amyloid-beta effects: Aβ oligomers disrupt SYT1 distribution and function at presynaptic terminals
Calcium dysregulation: Enhanced basal calcium levels in AD neurons may alter SYT1's calcium sensitivity
Therapeutic targeting: Restoring SYT1 function represents a potential therapeutic strategy for preserving synaptic transmission
Parkinson's Disease
In Parkinson's disease, SYT1 contributes to dopaminergic neuron dysfunction:
Vesicle pool dynamics: SYT1 dysfunction impairs synaptic vesicle recycling in dopaminergic neurons
Alpha-synuclein interaction: Pathological alpha-synuclein may interfere with SYT1-mediated vesicle fusion